BioSpace News Archive

Policy

DOJ Charges Teva Pharmaceutical In Ongoing Generics Price-Fixing Probe

The U.S. Department of Justice charged the Israel-based company with three counts of fixing prices to reap more than $350 million from customers through the scheme.

August 26, 2020
·
3 min read
·
Alex Keown
Career Advice

Time Management Tool: Using Time Blocking for Productive Work from Home

You can use a time management tool In order to exceed your office productivity while working from home. Here’s one such tool that you can use and boost performance.

August 26, 2020
·
2 min read
·
Laura Brothers
Genetown

Translate Bio and Sanofi’s COVID-19 Vaccine Positive in Animal Studies

In a regulatory filing with the U.S. Securities and Exchange Commission, Translate Bio indicated that the COVID-19 vaccine it is developing with Sanofi induced an immune response in non-human studies.

August 26, 2020
·
2 min read
·
Mark Terry
Drug Development

Takeda and Ovid’s Epilepsy Drug Sees Positive Results in Phase II Trial

Takeda Pharmaceutical and Ovid Therapeutics announced on Tuesday that they have gathered positive data from their Phase II ELEKTRA study of soticlestat in children with Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS).

August 26, 2020
·
3 min read
·
Krystle Vermes
BioSpace Global Roundup, Aug. 27

Biopharma and life sciences companies from around the globe share updates on their business practices and pipelines.

August 26, 2020
·
5 min read
·
Alex Keown
Biotech Bay

Freenome Raises $270 Million to Advance Colorectal Cancer Liquid Biopsy

South San Francisco-based Freenome closed on an oversubscribed $270 million Series C financing.

August 26, 2020
·
3 min read
·
Mark Terry
Drug Development

Phase I Data Suggests Moderna’s COVID-19 Vaccine is Effective Across Age Groups

Moderna presented more detailed data from the Phase I trial of its mRNA COVID-19 vaccine at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today.

August 26, 2020
·
3 min read
·
Mark Terry
Deals

ACADIA Pharma Acquires CerSci Therapeutics for $52 Million

The acquisition is expected to bolster ACADIA’s clinical pipeline to include non-opioid pain therapies that have potential non-addictive properties and reduced side effects typically seen with current opioid treatments.

August 26, 2020
·
2 min read
·
Alex Keown
Business

Detecting Coronavirus’ Structural Fingerprint as a Screening Method

Lasers aren’t just for directing presentations, playing tag or annoying cats. They can also serve as virus hunters.

August 26, 2020
·
6 min read
·
Chelsea Weidman Burke
Wireless Patient Monitoring Market: Increasing awareness and acceptance of telemedicine is expected to drive the market

Wireless patient monitoring devices are wireless and remote technologies that monitor and transmit data either within an institution or hospital via wireless or intranet, or at a remote location, using wireless transmissions.

August 26, 2020
·
5 min read